Role of the GMP facility for adoptive immunotherapy

By McMannis JD   Champlin RE  

Cytotherapy, Vol. 4, Iss. 4, 2002-07 ,pp. : 329-331

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease

By Hobeika Ac   Osada T.   Serra D.   Peplinski S.   Hanson K.   Tanaka Y.   Niedzwiecki D.   Chao N.   Rizzieri D.   Lyerly Hk   Clay T.   Morse Ma  

Cytotherapy, Vol. 10, Iss. 3, 2008-01 ,pp. : 289-302

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Immunotherapy for CMV infection

By Einsele H  

Cytotherapy, Vol. 4, Iss. 5, 2002-09 ,pp. : 435-436

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials

By Digiusto Dl   Cooper Ljn  

Cytotherapy, Vol. 9, Iss. 7, 2007-01 ,pp. : 613-629

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive cellular immunotherapy for non-small cell lung cancer: a pilot study

By Lo G   Ho G   Yeung Dw   Woo D   Chan B   Lee W   Hu Cxl   Ng P   Li Kw  

Cytotherapy, Vol. 5, Iss. 1, 2003-01 ,pp. : 46-54

Ashgate Publishing Ltd

Access to resources Recommend Favorite